Also trades as: SABS (NASDAQ) · $vol 2M
SABSW Institutional Ownership
SAB Biotherapeutics, Inc.
1W: -89.0%
1M: -92.1%
3M: -90.1%
YTD: -96.5%
1Y: -95.8%
3Y: -97.8%
$0.00
-0.00 (-74.42%)
Credit Risk of going bust: lower than 69% of companies Debt: 1.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down 99%), SAB Biotherapeutics, Inc. would be worth roughly what it owes.
Total debt $5.1M against a stock market value of $279.3M.
Distance to default 7.40 (Merton model): prices to 2026-10-21, balance sheet 2026-06-30, debt counted $2.9M (short-term plus half of long-term), stock volatility 60.6%; Altman Z'' 9.84. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down 99%), SAB Biotherapeutics, Inc. would be worth roughly what it owes.
Total debt $5.1M against a stock market value of $279.3M.
Distance to default 7.40 (Merton model): prices to 2026-10-21, balance sheet 2026-06-30, debt counted $2.9M (short-term plus half of long-term), stock volatility 60.6%; Altman Z'' 9.84. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Institutional Ownership — SABSW
8
Institutional Holders
-1 vs prior quarter
0.0%
Ownership
+0.00pp
$0M
Total Invested
1
New Positions
4
Increased
0
Reduced
0
Closed
0.00
Put/Call Ratio
Ownership Trends
Top Institutional Holders (9 total)
| # | Holder | Shares | Value | Change | Change % | Holding Period | Filing |
|---|---|---|---|---|---|---|---|
| 1 | LMR Partners LLP | 539,588 | $1K | — | +0.0% | 2Q | SEC ↗ |
| 2 | MORGAN STANLEY | 146,439 | $0K | — | +0.0% | 19Q | SEC ↗ |
| 3 | Clear Street Group Inc. | 79,033 | $0K | +300 | +0.4% | 4Q | SEC ↗ |
| 4 | GTS SECURITIES LLC | 41,301 | $0K | +300 | +0.7% | 3Q | SEC ↗ |
| 5 | UBS Group AG | 6,567 | $0K | +2,381 | +56.9% | 4Q | SEC ↗ |
| 6 | WOLVERINE ASSET MANAGEMENT LLC | 3,289 | $0K | +1,478 | +81.6% | 15Q | SEC ↗ |
| 7 | TORONTO DOMINION BANK NEW | 300 | $0K | — | +0.0% | 1Q | SEC ↗ |
| 8 | BANK OF AMERICA CORP /DE | 0 | $0K | -100 | -100.0% | 2Q | SEC ↗ |
| 9 | NewEdge Advisors, LLC | 0 | $0K | -1,072 | -100.0% | 12Q | SEC ↗ |
Recent Activity
New Positions (1)
| Holder | Shares | Value |
|---|---|---|
| TORONTO DOMINION BANK | 300 | $0K |
Sold Out (2)
| Holder | Prev Shares | Prev Value |
|---|---|---|
| NewEdge Advisors, LLC | 1,072 | $0K |
| BANK OF AMERICA CORP /DE | 100 | $0K |
Biggest Increases (4)
| Holder | Added | Change % | Total Shares |
|---|---|---|---|
| UBS Group AG | +2,381 | +56.9% | 6,567 |
| WOLVERINE ASSET MANAGEMENT LLC | +1,478 | +81.6% | 3,289 |
| GTS SECURITIES LLC | +300 | +0.7% | 41,301 |
| Clear Street Group Inc. | +300 | +0.4% | 79,033 |
Biggest Decreases (0)
None.